The Innovative Medicines Initiative (IMI) is the world’s largest public private partnership with a €5 Billion budget. For three years, Pierre Meulien has been the IMI’s Executive Director, bringing with him a wealth of international experience including a stint as the head of Genome Canada and founding Molecular Medicine Ireland. In this podcast we discuss the challenges of European healthcare, the evolution of the IMI since his appointment, and the role the IMI should play in Horizon Europe with the next commission.See omnystudio.com/listener for privacy information.